Negotiating Drug Prices in the US—Lessons From Europe
Bibliographic Data
| ID | 15808019 |
|---|---|
| Authors | Kerstin Noëlle Vokinger (0000-0002-6997-7384, University of Zurich, corresponding author), Huseyin Naci (0000-0002-7192-5751, London School of Economics and Political Science) |
| Year | 2022 |
| Volume | 3 |
| Issue | 12 |
| Pages | e224801-e224801 |
| Publication date | 2022-12-22 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | JAMA Health Forum (JOURNAL) |
| Journal identifiers | ISSN: 2689-0186 • E-ISSN: 2689-0186 |
| Publisher | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/jamahealthforum.2022.4801 |
| PMID | 36547946 |
| OpenAlex | W4312194207 |
| Language | EN |
| Citations received | 1 |
This Viewpoint describes European drug price negotiation practices and compares them with practices in the US
Business · Drug · Drug prices · Economics · Negotiation · Political science · Public economics · Economic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Law · Medicine · Pharmaceutical Economics and Policy · Pharmacology
| Unique citing works | 1 |
|---|---|
| Citations per year | 0.5 |
| Citation span | 2024 - 2024 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |